← Back to headlines
Medtronic's MiniMed Diabetes Unit Eyes $7.9 Billion Valuation in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking a valuation of $7.9 billion as it prepares for a US initial public offering.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
